It should be noted that anti-VEGF/anti-EGFR/chemotherapy regimens are under further investigation in more highly selected patient populations such as those with NSCLC (SWOG-S0819 [NCT00946712]). Here, VEGFA is linked to non-small cell lung carcinoma.